UA
35
2
TROW
56
-2
HPE
66
2
WAT
31
-2
DIS
61
-3
NTRS
52
-12
ISRG
52
2
PEP
59
-4
PX
73
-3
AAP
42
-2
AME
47
-6
YUM
61
2
EA
47
3
SHW
53
-5
ABBV
64
-2
IR
63
-2
FRT
48
-2
CINF
43
2
NSC
68
4
WMB
47
5
UA
35
2
TROW
56
-2
HPE
66
2
WAT
31
-2
DIS
61
-3
NTRS
52
-12
ISRG
52
2
PEP
59
-4
PX
73
-3
AAP
42
-2
AME
47
-6
YUM
61
2
EA
47
3
SHW
53
-5
ABBV
64
-2
IR
63
-2
FRT
48
-2
CINF
43
2
NSC
68
4
WMB
47
5
Financhill
Back

GitLab Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
63

GTLB
GitLab

Last Price:
$45.38
Seasonality Move:
-8.13%
Buy
57

HALO
Halozyme Therapeutics

Last Price:
$56.46
Seasonality Move:
-2.44%
Buy
63
GitLab (GTLB) is a Buy

Is GitLab a Buy, Sell or Hold?

  • The current GitLab [GTLB] share price is $45.37. The Score for GTLB is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GTLB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $56.45. The Score for HALO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GTLB Stock Price Chart

What is GitLab's stock price today?

  • The GitLab share price today is $45.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GTLB is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $56.45
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

GTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 12.19 Buy
Relative Strength Index (14 RSI): 53.02 Buy
Chaikin Money Flow: 3175298 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.87 - 45.63) Buy
Bollinger Bands (100): (42.58 - 52.82) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.9 Buy
Relative Strength Index (14 RSI): 54.54 Buy
Chaikin Money Flow: -1005700 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.67 - 56.61) Buy
Bollinger Bands (100): (53.56 - 62.32) Sell

GTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.92 Buy
20-day SMA: 44.14 Buy
50-day SMA: 46.14 Sell
200-day SMA: 54.34 Sell
8-day EMA: 39.4 Buy
20-day EMA: 26.16 Buy
50-day EMA: 13.35 Buy
200-day EMA: 3.8 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.23 Sell
20-day SMA: 54.86 Buy
50-day SMA: 55.13 Buy
200-day SMA: 55.39 Buy
8-day EMA: 51.22 Buy
20-day EMA: 33.92 Buy
50-day EMA: 17.27 Buy
200-day EMA: 4.91 Buy

GitLab Earnings Growth & GTLB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.02 per share, an increase this year of $0.50 per share, and an increase next year of $0.12 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.06 per share, an increase this year of $1.27 per share, and an increase next year of $1.48 per share.

GitLab Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):